According to filings with the U.S. Securities and Exchange Commission, Channel Robotics has raised $4,600,000.00 in new Seed funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

Investors in the company’s current round of funding include: Infinity Ventures, Sella Direct Ventures, Frontline, and Y Combinator

About Channel Robotics
Channel Robotics is a San Diego-based medical technology company developing a next-generation endoscopic robotic platform designed to enhance physician dexterity and expand access to advanced minimally invasive procedures. Founded by a physician-scientist Dr. Philip Weissbrod and roboticist Dr. Michael Yip, the company is focused on creating practical, scalable robotic solutions that integrate seamlessly into existing clinical workflows. Channel’s technology combines novel robotic instrumentation, intuitive control systems, and artificial intelligence to enable more precise and accessible endoscopic interventions.

To learn more, visit https://www.channelrobotics.com/
Linkedin: https://www.linkedin.com/company/channel-robotics/

Contact:
Philip Weissbrod, Chief Executive Officer
https://www.linkedin.com/in/philip-a-weissbrod-md-3b9130256/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.